Buy Soriatane

Soriatane

What is Soriatane?

Soriatane contains acitretin as its active component. It is an oral pill available in a 10 mg strength and is classified as a retinoid medication. In Hong Kong, Soriatane is a prescription-only drug regulated by the Department of Health. The medication is primarily indicated for severe psoriasis and other disorders of keratinisation.

How Soriatane Works in the Body

Acitretin is a second-generation synthetic retinoid that binds to nuclear retinoic acid receptors (RAR-α, RAR-β, and RAR-γ). Activation of these receptors modulates gene expression involved in cell differentiation and proliferation. By normalising keratinocyte growth, acitretin reduces the thickened, scaly plaques characteristic of severe psoriasis. The drug has a relatively long half-life (up to 100 hours) and reaches peak plasma concentrations within 2-4 hours after oral ingestion.

Conditions Treated by Soriatane

• Severe plaque psoriasis that does not respond adequately to topical therapy or phototherapy.
• Disorders of keratinisation such as ichthyosis.

These indications are approved by the Hong Kong Department of Health and align with the product’s regulatory labeling.

Patient Suitability and Contraindications

Who Should Consider Soriatane?

• Adults with severe, chronic plaque psoriasis or related keratinisation disorders.
• Patients who have not achieved control with less systemic options.

Absolute Contraindications

• Known hypersensitivity to acitretin or any ingredient of the formulation.
• Pregnancy or planning to become pregnant (see teratogenicity below).
• Active uncontrolled liver disease.

Relative Contraindications

• Significant hyperlipidaemia that is not well-controlled.
• Alcohol dependence, as alcohol can increase the conversion of acitretin to its more teratogenic metabolite, etretinate.
• Severe renal impairment (dose adjustment may be required).

Special Populations

• Pregnancy and lactation: Acitretin is highly teratogenic. Women must use effective contraception for at least three years after stopping therapy.
• Elderly: Dose may need to be reduced because of increased risk of hyperlipidaemia and hepatic sensitivity.
• Pediatric use: Not approved; safety and efficacy have not been established in children.

Safety Profile: Side Effects and Interactions

Common Side Effects

• Dry skin and lips - frequently reported; moisturisers can help.
• Hair thinning - usually mild and reversible.
• Elevated liver enzymes - monitored with routine blood tests.
• Hypertriglyceridaemia - lipid profiles should be checked periodically.

Serious Adverse Events

• Severe hepatotoxicity - indicated by marked rise in transaminases; discontinue if confirmed.
• Pseudotumor cerebri - rare but requires immediate medical attention.
• Severe hyperlipidaemia - may precipitate pancreatitis; manage with lipid-lowering agents or dose adjustment.

Drug Interactions

• Tetracyclines (e.g., doxycycline): May increase intracranial pressure risk.
• Vitamin A supplements: Additive teratogenic potential; avoid concurrent use.
• Systemic corticosteroids: May reduce acitretin efficacy.
• Cytochrome P450 inducers (e.g., carbamazepine, phenytoin): May lower acitretin plasma levels.

Food and Lifestyle Interactions

• Alcohol: Increases conversion to etretinate, prolonging teratogenic risk; limit intake.
• High-fat meals: May modestly enhance absorption, but do not affect overall efficacy.
• Driving or operating machinery: Generally not impaired, but severe dizziness may occur in a minority of patients.

How to Take Soriatane

• Standard dosing: The usual starting dose is 10 mg taken orally once daily with a glass of water. Dose may be increased gradually up to 25 mg daily based on clinical response and tolerability, but the available tablet strength is 10 mg.
• Administration tips: Swallow the pill whole; do not crush or chew. It can be taken with or without food.
• Missed dose: Take the missed dose as soon as remembered unless the next scheduled dose is within a few hours. Do not double the dose.
• Overdose: Symptoms may include severe nausea, vomiting, and headache. Seek emergency medical care; supportive treatment is the mainstay.
• Discontinuation: No tapering is required for acitretin; however, abrupt cessation may lead to rapid relapse of psoriasis. Discuss maintenance strategies with a healthcare provider.

Dosing must always be individualized by a qualified prescriber, who will consider liver function, lipid profile, and pregnancy status.

Monitoring and Follow-Up

• Baseline labs: Liver function tests (ALT, AST, bilirubin) and fasting lipid panel before initiating therapy.
• Routine monitoring: Repeat liver enzymes and lipid panel every 4-8 weeks during the first 3 months, then every 3-6 months thereafter.
• Pregnancy testing: Women of child-bearing potential must have a negative pregnancy test before starting and before each refill.
• Clinical assessment: Evaluate skin response and adverse effects at each follow-up visit.

Storage and Handling

• Store Soriatane tablets at room temperature (20-25 °C) away from excess moisture and light.
• Keep the medication out of reach of children.
• Do not use after the expiration date printed on the label.

Medication-Specific Glossary

Retinoid

A class of compounds structurally related to vitamin A that influence cell growth and differentiation.

Teratogenicity

The capacity of a substance to cause birth defects when exposure occurs during pregnancy.

Hypertriglyceridaemia

Elevated levels of triglycerides in the blood, a potential side effect of retinoid therapy.

Keratinisation

The process by which skin cells produce keratin, a protective protein; dysregulation leads to disorders like psoriasis.

Medical Disclaimer

This article provides educational information about Soriatane and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.